48W-18601-37314
4 vaccinations
1 coded response
18 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 405 / KY
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Registered in v-safe
- 2021-01-26
- 2021-02-09
-
2021-02-15
Dose 2 — Pfizer-BioNTech
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-22
Survey response — day 7, dose 2MedDRA: Office visit — Feeling: Fair · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to work, Get care from a doctor or other healthcare professionalFree text: Visited my general practitionerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Report sent to call center — day 7, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-10
- 2021-03-22
- 2021-03-30
- 2021-08-31
-
2021-10-22
Dose 3 — Pfizer-BioNTech
- 2022-02-17
-
2022-09-15
Dose 4 — Pfizer-BioNTech
- 2022-10-04
- 2022-10-06
- 2022-10-20
- 2022-10-27
- 2022-12-15
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
| 4 | 2022-09-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-22 | Unsuccessful |
Free text
Release 4 — day 7, dose 2
Healthcare visit (other): Visited my general practitioner
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release